Loading...
Market
Which company will acquire the rights to the new injection by the end of 2025?
2
Resolution / Starting Odds
Pfizer • 25%
AstraZeneca • 25%
GlaxoSmithKline • 25%
Other • 25%
Official press releases from pharmaceutical companies
Story
UK Scientists Develop First Game-Changing Injection for Asthma and COPD Treatment, Reducing Further Treatment Needs by 30%
Dec 2, 2024, 12:53 PM
UK scientists have developed a new injection that represents the first major advancement in asthma treatment in 50 years. This innovative therapy has been shown to be more effective than traditional steroid tablets, reducing the need for additional treatments by 30%, according to a recent study. The injection is expected to significantly change the management of asthma and Chronic Obstructive Pulmonary Disease (COPD), marking a pivotal moment in respiratory care.
View original story
Similar markets
Pfizer • 25%
Johnson & Johnson • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Novartis • 25%
Novo Nordisk • 25%
Sanofi • 25%
Merck • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Biotech company • 25%
Pharmaceutical company • 25%
Medical device company • 25%
Other • 25%
Yes • 50%
No • 50%
Novo Nordisk • 25%
Sanofi • 25%
Eli Lilly • 25%
Other • 25%